Brief: Aeon Biopharma Approves 1-For-72 Reverse Stock Split
Feb 24 (Reuters) - Aeon Biopharma Inc AEON.A :
* AEON BIOPHARMA, INC. ANNOUNCES REVERSE STOCK SPLIT
* AEON BIOPHARMA INC - APPROVES 1-FOR-72 REVERSE STOCK SPLIT
Source text: ID:nGNX3Jvh7l
Further company coverage: AEON.A
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition